Abstract:Autophagy has been implicated in the process of liver fibrosis. However, the exact relationships between autophagy and liver fibrosis are still not clear and whether autophagy accelerates or ameliorates fibrosis remains to be elucidated. Unc-51 like autophagy activating kinase 1 (ULK1) mediated autophagy control may play a vital role. Liver fibrosis was induced by carbon tetrachloride (CCl4). Mice were divided into two groups, a wild-type (WT) group and an ULK1 Knockout (ULK1 KO) group. Hematoxyline-eosin (H&E) and Masson staining were then used to evaluate the success of the liver fibrosis model. ELISA was used to analyze the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TB). Immunohistochemical staining (IHC) was used to detect the expressions of pro-fibrogenic genes, such as α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1). ULK1 KO mice had better liver function and mild fibrosis than WT mice (P <0.05). Compared with the WT mice, autophagy flux as indicated by the accumulation of LC3-II and degradation of p62 was down regulated in ULK1 KO mice (P <0.05). All the changes were aggravated as time increased. Our results suggest that ULK1 KO exerts beneficial effects in CCl4-induced liver fibrosis, and the moderate inhibition of autophagic activity may be a new strategy for treating liver fibrosis.

Unc-51 Like Autophagy Activating Kinase 1 Knockout Protects Against Carbon Tetrachloride-induced Liver Fibrosis: the Role of Autophagy